Glutathione peroxidase 4 overexpression inhibits ROS-induced cell death in diffuse large B-cell lymphoma

Laboratory Investigation

Volumn 98, Issue 5, 2018, Pages 609-619

  Kinowaki, Yuko ^a   Kurata, Morito ^a   Ishibashi, Sachiko ^a   Ikeda, Masumi ^a   Tatsuzawa, Anna ^a,b   Yamamoto, Masahide ^a   Miura, Osamu ^a   Kitagawa, Masanobu ^a   Yamamoto, Kouhei ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b BUNKYO GAKUIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CYCLOPHOSPHAMIDE; CYCLOPHOSPHAMIDE PLUS DOXORUBICIN PLUS PREDNISOLONE PLUS RITUXIMAB PLUS VINCRISTINE; DOXORUBICIN; ETOPOSIDE; LACTATE DEHYDROGENASE; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; PREDNISOLONE; REACTIVE OXYGEN METABOLITE; VINCRISTINE; 8-OXO-7-HYDRODEOXYGUANOSINE; DEOXYGUANOSINE; GLUTATHIONE PEROXIDASE; PHOSPHOLIPID-HYDROPEROXIDE GLUTATHIONE PEROXIDASE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CELL DEATH; CELL VIABILITY; DIFFUSE LARGE B CELL LYMPHOMA; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANALOGS AND DERIVATIVES; APOPTOSIS; CELL CULTURE; ENZYMOLOGY; GENETICS; METABOLISM; MORTALITY; PATHOLOGY; PHYSIOLOGY;

APOPTOSIS; CELLS, CULTURED; DEOXYGUANOSINE; GLUTATHIONE PEROXIDASE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; REACTIVE OXYGEN SPECIES;

EID: 85042228290     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/s41374-017-0008-1     Document Type: Article

References (41)

1. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. Lyon, France: IARC; 2008.
2. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375-2390.
3. Hu S, Xu-Monette ZY, Balasubramanyam A, et al. CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Blood. 2013;121:2715-2724.
4. Ennishi D, Takeuchi K, Yokoyama M, et al. CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy. Ann Oncol. 2008;19:1921-1926.
5. Yamaguchi M, Seto M, Okamoto M, et al. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood. 2002;99:815-821.
6. Lincoln DT, Ali Emadi EM, Tonissen KF, et al. The thioredoxinthioredoxin reductase system: over-expression in human cancer. Anticancer Res. 2003;23:2425.
7. Jan L, Sandra JH, Ying H, et al. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal. 2013;18:522-555.
8. Le J, Ning K, Tongyuan L, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520:557.
9. Gandin V, Fernandes AP, Rigobello MP, et al. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase. Biochem Pharmacol. 2010;79:90-101.
10. Chao Y, Biehuoy S, Philip R, et al. Potent activity of indolequinones against human pancreatic cancer: identification of thioredoxin reductase as a potential targaet. Mol Pharmacol. 2009;76:163-172.
11. Tobe R, Yoo MH, Fradejas N, et al. Thioredoxin reductase 1 deficiency enhances selenite toxicity in cancer cells via a thioredoxin-independent mechanism. Biochem J. 2012;445:423-430.
12. Seiler A, Schneider M, Förster H, et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent-and AIF-mediated cell death. Cell Metab. 2008;8:237-248.
13. Wortmann M, Schneider M, Pircher J, et al. Combined deficiency in glutathione peroxidase 4 and vitamin E causes multiorgan thrombus formation and early death in mice. Circ Res. 2013;113:408-417.
14. Yant LJ, Ran Q, Rao L, et al. The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radic Biol Med. 2003;34:496-502.
15. Yagublu V, Arthur JR, Babayeva SN, et al. Expression of selenium-containing proteins in human colon carcinoma tissue. Anticancer Res. 2011;31:2693.
16. Guerriero E, Capone F, Accardo M, et al. GPX4 and GPX7 overexpression in human hepatocellular carcinoma tissues. Eur J Histochem. 2015;59:2540.
17. Liu J, Du J, Zhang Y, et al. Suppression of the malignant phenotype in pancreatic cancer by overexpression of phospholipid hydroperoxide glutathione peroxidase. Hum Gene Ther. 2006;17:105-116.
18. Cejas P, García-Cabezas MA, Casado E, et al. Phospholipid hydroperoxide glutathione peroxidase (PHGPx) expression is downregulated in poorly differentiated breast invasive ductal carcinoma. Free Radic Res. 2007;41:681-687.
19. Rudenko E, Kondratov O, Gerashchenko G, et al. Aberrant expression of selenium-containing glutathione peroxidases in clear cell renal cell carcinomas. Exp Oncol. 2015;37:105.
20. Van Blarigan EL, Ma J, Kenfield SA, et al. Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival. Cancer Epidemiol Biomark Prev. 2014; 23:1037-1046.
21. Lan X, Xing J, Gao H, et al. Decreased expression of selenoproteins as a poor prognosticator of gastric cancer in humans. Biol Trace Elem Res. 2017;178:22-28.
22. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275-282.
23. Yoshimori M, Imadome K-I, Komatsu H, et al. CD137 expression is induced by Epstein-Barr virus infection through LMP1 in T or NK cells and mediates survival promoting signals. PLoS ONE. 2014;9:e112564.
24. Hafer K, Schiestl RH. Biological aspects of dichlorofluorescein measurement of cellular reactive oxygen species. Radiat Res. 2008;170:408.
25. Grinberg YY, van Drongelen W, Kraig RP. Insulin-like growth factor-1 lowers spreading depression susceptibility and reduces oxidative stress. J Neurochem. 2012;122:221-229.
26. Bhattacharya S, Gachhui R, Sil PC. Hepatoprotective properties of kombucha tea against TBHP-induced oxidative stress via suppression of mitochondria dependent apoptosis. Pathophysiology. 2011;18:221-234.
27. Vessey DA, Lee KH, Blacker KL. Characterization of the oxidative stress initiated in cultured human keratinocytes by treatment with peroxides. J Invest Dermatol. 1992;99: 859-863.
28. Ueta T, Inoue T, Furukawa T, et al. Glutathione peroxidase 4 is required for maturation of photoreceptor cells. J Biol Chem. 2012;287:7675-7682.
29. Imai H, Suzuki K, Ishizaka K, et al. Failure of the expression of phospholipid hydroperoxide glutathione peroxidase in the spermatozoa of human infertile males1. Biol Reprod. 2001; 64:674-683.
30. Imai H, Hirao F, Sakamoto T, et al. Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene. Biochem Biophys Res Commun. 2003;305:278-286.
31. Roveri A, Maiorino M, Ursini F. Enzymatic and immunological measurements of soluble and membrane-bound phospholipidhydroperoxide glutathione peroxidase. Methods Enzymol. 1994;233:202-212.
32. Uhlen M, Fagerberg L, Hallstroem BM, et al. Tissue-based map of the human proteome. Science. 2015;347:394.
33. Brown KM, Pickard K, Nicol F, et al. Effects of organic and inorganic selenium supplementation on selenoenzyme activity in blood lymphoctyes, granulocytes, platelets and erythrocytes. Clin Sci. 2000;98:593.
34. Boulon S, Westman BJ, Hutten S, et al. The nucleolus under stress. Mol Cell. 2010;40:216-227.
35. Peroja P, Pasanen AK, Haapasaari KM, et al. Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma. Exp Hematol Oncol. 2012;1:2.
36. Harris IS, Brugge JS. Cancer: the enemy of my enemy is my friend. Nature. 2015;527:170-1.
37. Andreadis C, Gimotty PA, Wahl P, et al. Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma. Blood. 2007;109:3409-3406.
38. DeNicola GM, Karreth FA, Humpton TJ, et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature. 2011;475:106-109.
39. Yang Wan S, SriRamaratnam R, Welsch Matthew E, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317-331.
40. Cao JY, Dixon SJ. Mechanisms of ferroptosis. Cell Mol Life Sci. 2016;73:2195-2209.
41. Sakamoto K, Sogabe S, Kamada Y, et al. Discovery of GPX4 inhibitory peptides from random peptide T7 phage display and subsequent structural analysis. Biochem Biophys Res Commun. 2017;482:195-201.